Anticorps Recombinant de lapin anti-Phospho-p70(S6K) (Thr389)/p85(S6K) (Thr412)

Phospho-p70(S6K) (Thr389)/p85(S6K) (Thr412) Recombinant Antibody for WB, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

1G15

N° de cat : 82373-1-PBS

Synonymes

p p70(S6K), p p70(S6K) (Thr389), p p70(S6K) Thr389, P p85(S6K) (Thr412), p70(S6K) (Thr389)



Informations sur le produit

82373-1-PBS cible Phospho-p70(S6K) (Thr389)/p85(S6K) (Thr412) dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Peptide
Nom complet ribosomal protein S6 kinase, 70kDa, polypeptide 1
Poids moléculaire observé65-85 kDa
Numéro d’acquisition GenBankNM_003161
Symbole du gène p70 S6K
Identification du gène (NCBI) 6198
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

The Rps6kb1 gene encodes the 70 kDa ribosomal protein S6 kinase (p70S6K), which is a serine/threonine kinase regulated by phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) pathway. P70(S6K) plays a crucial role in controlling cell cycle, growth and survival. The PI3K/mTOR signalling pathway is one of the major mechanisms for controlling cell survival, proliferation and metabolism and is the central regulator of translation of some components of protein synthesis system. Due to alternative translation two isoform S6K1 proteins are known to exist in mammalian cells: p85(S6K) and p70(S6K), which is identical to p85(S6K) but lacks its first 23 amino acids. In addition, mammalian cells express a second S6K1 isoform spanning 316 amino acids (p31 S6K1). mTOR is know to phosphorylate and thereby activate p70(S6K) at Thr389 and p85(S6K) at Thr412. (PMID: 25100792, PMID: 24970012, PMID: 21602892)

{{ptg:RelatedPrimaryAntibodies}}